# PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdel

> **NCT03199950** · PHASE4 · UNKNOWN · sponsor: **Zuyderland Medisch Centrum** · enrollment: 1366 (estimated)

## Conditions studied

- Delirium

## Interventions

- **DRUG:** Haloperidol
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03199950
- **Lead sponsor:** Zuyderland Medisch Centrum
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-23
- **Primary completion:** 2018-11-23
- **Final completion:** 2018-11-23
- **Target enrollment:** 1366 (ESTIMATED)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03199950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03199950, "PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdel". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03199950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*